enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. CRISPR Therapeutics - Wikipedia

   en.wikipedia.org/wiki/CRISPR_Therapeutics

   Subsequently, CRISPR Therapeutics and Vertex expanded their collaboration to include diseases like Duchenne muscular dystrophy and type 1 diabetes. [9] [10] In 2016, the company signed an agreement with Bayer AG to operate Casebia Therapeutics as a joint venture with Bayer under the management of CRISPR Therapeutics. [11]

3. 2 Biotech Stocks That Are Screaming Buys This Month - AOL

   www.aol.com/2-biotech-stocks-screaming-buys...

   CRISPR Therapeutics recently hit a breakthrough point when it earned approval for its first product, Casgevy, a therapy for sickle cell disease and transfusion-dependent beta-thalassemia.

4. CRISPR Therapeutics Presents Data at the 2024 American ...

   lite.aol.com/tech/story/0022/20241209/9316263.htm

   ZUG, Switzerland and BOSTON, Dec. 09, 2024 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today presented data from the Company’s ongoing Phase 1/2 dose escalation clinical trial evaluating the safety and efficacy of CTX112™, a ...

5. Innovative Genomics Institute - Wikipedia

   en.wikipedia.org/wiki/Innovative_Genomics_Institute

   In addition to CRISPR research, the IGI works to advance public understanding of CRISPR and genome engineering and guide the ethical use of these technologies. Free public resources include: CRISPRpedia — a free textbook-style resource for learning about the biology, applications, and ethics of CRISPR and genome editing, with chapters edited ...

6. 1 Big New Green Flag for CRISPR Therapeutics' Stock - AOL

   www.aol.com/finance/1-big-green-flag-crispr...

   CRISPR Therapeutics (NASDAQ: CRSP) isn't a stock that's wanting for reasons to invest. Per the company's presentation at the American Society of Hematology's (ASH) annual meeting on Dec. 9, the ...

7. Vertex Pharmaceuticals - Wikipedia

   en.wikipedia.org/wiki/Vertex_Pharmaceuticals

   In 2015, Vertex entered into a research collaboration with CRISPR Therapeutics to develop gene-editing therapies for genetic diseases. [38] In May 2020, CTX001 has received Orphan Drug Designation from the U.S. Food and Drug Administration for transfusion-dependent beta thalassemia and from the European Medicines Agency for sickle cell disease ...

8. US FDA approves Vertex/CRISPR gene therapy for an ... - AOL

   www.aol.com/news/us-fda-approves-vertex-crispr...

   24/7 Help. For premium support please call: 800-290-4726

9. CRISPR gene editing - Wikipedia

   en.wikipedia.org/wiki/CRISPR_gene_editing

   CRISPR is used to edit the cells in order to reduce the chance the patient's body will reject the transplant. On November 17, 2021 CRISPR therapeutics and ViaCyte announced that the Canadian medical agency had approved their request for a clinical trial for VCTX210, a CRISPR-edited stem cell therapy designed to treat type 1 diabetes.